Crossref
Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act
Diabetes Care · 20.11.2026
DOI: 10.2337/dc26-2122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 20.11.2026. Verfasst von Michael Fang und 5 weiteren Autor:innen. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute, Arnold Ventures.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
- Arnold Ventures
- American Heart Association
Zitieren
APA
Fang, M., Dun, C., Hicks, C. W., Selvin, E., Shin, J., & Socal, M. P. (2026). Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act. Diabetes Care. https://doi.org/10.2337/dc26-2122
Vancouver
Fang M, Dun C, Hicks CW, Selvin E, Shin J, Socal MP. Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act. Diabetes Care. 2026. doi:10.2337/dc26-2122
BibTeX
@article{Fang2026,
author = {Fang, Michael and Dun, Chen and Hicks, Caitlin W. and Selvin, Elizabeth and Shin, Jung-Im and Socal, Mariana P.},
title = {Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act},
journal = {Diabetes Care},
year = {2026},
doi = {10.2337/dc26-2122}
}
EUVIMED